Heteronemin Attenuates LPS-Induced Oxidative Stress and Inflammatory Responses in RAW264.7 Macrophages
Marine Drugs · 2026
DOI: 10.3390/md24100351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2026. Verfasst von Su-Jin Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Korea Institute of Ocean Science and Technology, 2670, Iljudong-ro, Gujwa-eup, Jeju-si 63349, Republic of Korea. Hauptthemen laut MEDLINE: Oxidative Stress, Macrophages, Anti-Inflammatory Agents, Inflammation. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Marine Science and Technology Promotion, Korea Institute of Ocean Science and Technology.
Abstract (Originalsprache)
Marine-derived natural products have attracted considerable attention as potential anti-inflammatory agents. Although the anticancer and pro-oxidative effects of heteronemin, a marine sponge-derived scalarane-type sesterterpenoid, have been reported, its direct regulatory effects on inflammatory mediator production in activated macrophages remain unclear. In this study, we aimed to investigate the anti-inflammatory effects of heteronemin in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. Heteronemin significantly suppressed LPS-induced nitric oxide production at concentrations up to 10 μM with minimal effects on cell viability. In addition, heteronemin reduced the expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), attenuated intracellular reactive oxygen species (ROS) accumulation, and downregulated pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). Furthermore, heteronemin treatment was associated with reduced phosphorylation of mitogen-activated protein kinases (MAPKs), including p38, JNK, and ERK, following prolonged LPS stimulation. In contrast to its previously reported ROS-inducing activity in cancer cells, heteronemin reduced inflammation-associated ROS accumulation and was associated with decreased MAPK phosphorylation in LPS-stimulated macrophages, suggesting that its effects on cellular redox responses may depend on the experimental context. Collectively, these findings suggest the therapeutic potential of heteronemin as a promising marine-derived lead compound for inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Korea Institute of Ocean Science and Technology, 2670, Iljudong-ro, Gujwa-eup, Jeju-si 63349, Republic of Korea.
- Korea Institute of Ocean Science and Technology, 385, Haeyang-ro, Yeongdo-gu, Busan Metropolitan City 49111, Republic of Korea.
- Department of Marine Technology and Convergence Engineering, University of Science and Technology, Daejeon 34113, Republic of Korea.
ORCID-Profile: Su-Jin Lee, Long Hoang To, Chulhong Oh, Gun-Hoo Park, Yeon-Ju Lee
Förderung
- Korea Institute of Marine Science and Technology Promotion
- Korea Institute of Ocean Science and Technology
Zitieren
APA
Lee, S. J., To, L. H., Oh, C., Park, G. H., & Lee, Y. J. (2026). Heteronemin Attenuates LPS-Induced Oxidative Stress and Inflammatory Responses in RAW264.7 Macrophages. Marine Drugs. https://doi.org/10.3390/md24100351
Vancouver
Lee SJ, To LH, Oh C, Park GH, Lee YJ. Heteronemin Attenuates LPS-Induced Oxidative Stress and Inflammatory Responses in RAW264.7 Macrophages. Marine Drugs. 2026. doi:10.3390/md24100351
BibTeX
@article{Lee2026,
author = {Lee, Su-Jin and To, Long Hoang and Oh, Chulhong and Park, Gun-Hoo and Lee, Yeon-Ju},
title = {Heteronemin Attenuates LPS-Induced Oxidative Stress and Inflammatory Responses in RAW264.7 Macrophages},
journal = {Marine Drugs},
year = {2026},
doi = {10.3390/md24100351}
}
EUVIMED